CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank33
3Y CAGR-26.1%
5Y CAGR-16.6%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-26.1%/yr
Annual compound
5Y CAGR
-16.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | -64.1% |
| 2024 | 0.08 | +12.4% |
| 2023 | 0.07 | +0.1% |
| 2022 | 0.07 | +8.4% |
| 2021 | 0.06 | -7.9% |
| 2020 | 0.07 | -14.5% |
| 2019 | 0.08 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |